These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
F
or the transition period from ______ to ______
|
| Delaware | 11-3027591 | |
| ( State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.)
|
|
445 Park Avenue, Suite 1020
New York, New York
|
10022
|
|
|
(Address of principal executive offices)
|
(zip code)
|
| Large accelerated filer ¨ | Accelerated filer ¨ |
Non-accelerated filer
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company x |
| Page No. | ||
|
|
FINANCIAL INFORMATION | |
| Item 1. |
Financial Statements
|
|
|
Condensed Balance Sheets as of September 30, 2013 (unaudited)
and December 31, 2012
|
3 | |
|
Condensed Statements of Income and Comprehensive Income
for the three and nine months ended September 30, 2013 and
2012 (unaudited)
|
4 | |
|
Condensed Statements of Cash Flows for the nine months
ended September 30, 2013 and 2012 (unaudited)
|
5 | |
|
Notes to Interim Unaudited Condensed Financial Statements
|
6 | |
| Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 19 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 28 |
| Item 4. | Controls and Procedures | 28 |
|
|
OTHER INFORMATION | |
| Item 1. | Legal Proceedings | 28 |
| Item 1A. | Risk Factors | 30 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 31 |
| Item 3. | Defaults Upon Senior Securities | 32 |
| Item 5. | Other Information | 32 |
| Item 6. | Exhibits | 33 |
| SIGNATURES | 34 | |
| SEPTEMBER 30, | DECEMBER 31, | |||||||
| 2013 | 2012 | |||||||
| (UNAUDITED) | ||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$ | 19,584,000 | $ | 21,983,000 | ||||
|
Marketable securities
|
532,000 | 547,000 | ||||||
|
Royalty receivables
|
1,127,000 | 775,000 | ||||||
|
Other current assets
|
198,000 | 222,000 | ||||||
|
Total Current Assets
|
$ | 21,441,000 | $ | 23,527,000 | ||||
|
OTHER ASSETS:
|
||||||||
|
Deferred tax asset
|
$ | 6,002,000 | 6,194,000 | |||||
|
Patents, net of accumulated amortization
|
5,355,000 | 65,000 | ||||||
|
Other Investments
|
196,000 | — | ||||||
|
Security deposits
|
19,000 | 19,000 | ||||||
|
Total Other Assets
|
$ | 11,572,000 | $ | 6,278,000 | ||||
|
TOTAL ASSETS
|
$ | 33,013,000 | $ | 29,805,000 | ||||
|
LIABILITIES:
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Accounts payable
|
$ | 107,000 | $ | 232,000 | ||||
|
Accrued expenses
|
460,000 | 593,000 | ||||||
|
TOTAL LIABILITIES
|
567,000 | 825,000 | ||||||
|
COMMITMENTS AND CONTINGENCIES
|
— | — | ||||||
|
STOCKHOLDERS' EQUITY
|
||||||||
|
Common stock - $0.01 par value; authorized 50,000,000 shares; 26,089,483 and 25,392,269 shares issued and outstanding at September 30,2013 and December 31,2012, respectively
|
261,000 | 254,000 | ||||||
|
Additional paid-in capital
|
$ | 61,046,000 | $ | 58,046,000 | ||||
|
Accumulated deficit
|
(28,832,000 | ) | (29,306,000 | ) | ||||
|
Other comprehensive income(loss)
|
(29,000 | ) | (14,000 | ) | ||||
|
TOTAL STOCKHOLDERS' EQUITY
|
32,446,000 | 28,980,000 | ||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY
|
$ | 33,013,000 | $ | 29,805,000 | ||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
|||||||||||||
|
ROYALTY REVENUE
|
$ | 1,227,000 | $ | 1,418,000 | $ | 7,198,000 | $ | 7,809,000 | ||||||||
|
COST OF REVENUE
|
345,000 | 393,000 | 2,117,000 | 2,341,000 | ||||||||||||
|
GROSS PROFIT
|
882,000 | 1,025,000 | 5,081,000 | 5,468,000 | ||||||||||||
|
OPERATING EXPENSES:
|
||||||||||||||||
|
General and Administrative
|
738,000 | 622,000 | 1,933,000 | 1,653,000 | ||||||||||||
|
Amortization of Patents
|
418,000 | 2,000 | 668,000 | 7,000 | ||||||||||||
|
Non-Cash compensation
|
70,000 | 58,000 | 326,000 | 223,000 | ||||||||||||
|
TOTAL OPERATING EXPENSES
|
1,226,000 | 682,000 | 2,927,000 | 1,883,000 | ||||||||||||
|
OPERATING INCOME (LOSS)
|
(344,000 | ) | 343,000 | 2,154,000 | 3,585,000 | |||||||||||
|
OTHER INCOME (EXPENSES):
|
||||||||||||||||
|
Interest income, net
|
9,000 | 3,000 | 27,000 | 22,000 | ||||||||||||
|
INCOME (LOSS) BEFORE INCOME TAXES
|
(335,000 | ) | 346,000 | 2,181,000 | 3,607,000 | |||||||||||
|
INCOME TAXES (BENEFIT)
|
||||||||||||||||
|
Current
|
(3,000 | ) | 11,000 | 23,000 | 44,000 | |||||||||||
|
Deferred
|
(124,000 | ) | 141,000 | 192,000 | 709,000 | |||||||||||
|
Total Income Taxes (Benefits)
|
(127,000 | ) | 152,000 | 215,000 | 753,000 | |||||||||||
|
NET INCOME (LOSS)
|
$ | (208,000 | ) | $ | 194,000 | $ | 1,966,000 | $ | 2,854,000 | |||||||
|
Net Income per share - Basic
|
$ | (.01 | ) | $ | 0.01 | $ | .08 | $ | 0.11 | |||||||
|
- Diluted
|
$ | (.01 | ) | $ | 0.01 | $ | .07 | $ | 0.10 | |||||||
|
Weighted average number of common shares outstanding:
|
||||||||||||||||
|
- Basic
|
25,792,387 | 25,963,093 | 25,387,348 | 25,659,085 | ||||||||||||
|
- Diluted
|
28,189,583 | 28,516,642 | 27,462,358 | 28,544,972 | ||||||||||||
|
NET INCOME (LOSS)
|
$ | (208,000 | ) | $ | 194,000 | $ | 1,966,000 | $ | 2,854,000 | |||||||
| OTHER COMPREHENSIVE INCOME NET OF TAX: | ||||||||||||||||
|
Unrealized gain (loss) arising during period
|
(1,000 | ) | (6,000 | ) | (15,000 | ) | (4,000 | ) | ||||||||
|
COMPREHENSIVE INCOME (LOSS)
|
$ | (209,000 | ) | $ | 188,000 | $ | 1,951,000 | $ | 2,850,000 | |||||||
| Nine Months Ended September 30, | ||||||||
| 2013 | 2012 | |||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net Income
|
$ | 1,966,000 | $ | 2,854,000 | ||||
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
||||||||
|
Amortization of Patents
|
668,000 | 7,000 | ||||||
|
Stock based compensation
|
326,000 | 223,000 | ||||||
|
Non-cash royalty revenue
|
(70,000 | ) | — | |||||
|
Source (use) of cash from changes in operating assets and liabilities:
|
||||||||
|
Royalty receivables and other current assets
|
(279,000 | ) | (596,000 | ) | ||||
|
Accounts payable and accrued expenses
|
(255,000 | ) | (1,052,000 | ) | ||||
|
Income taxes payable and accrued expense
|
(53,000 | ) | (54,000 | ) | ||||
|
Deferred tax asset
|
192,000 | 709,000 | ||||||
|
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
|
2,495,000 | 2,091,000 | ||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Purchase of patents and other assets
|
(4,417,000 | ) | — | |||||
|
Investments
|
(50,000 | ) | — | |||||
|
NET CASH USED IN INVESTING ACTIVITIES
|
(4,467,000 | ) | — | |||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Value of shares delivered to fund withholding taxes
|
(486,000 | ) | (487,000 | ) | ||||
|
Repurchase of treasury stock
|
(1,017,000 | ) | (52,000 | ) | ||||
|
Proceeds from exercises of options and warrants
|
1,076,000 | — | ||||||
|
NET CASH PROVIDED (USED IN) FINANCING ACTIVITIES
|
(427,000 | ) | (539,000 | ) | ||||
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
(2,399,000 | ) | 1,552,000 | |||||
|
CASH AND CASH EQUIVALENTS, beginning of period
|
21,983,000 | 20,661,000 | ||||||
|
CASH AND CASH EQUIVALENTS, end of period
|
$ | 19,584,000 | $ | 22,213,000 | ||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
|
Cash paid during the periods for:
|
||||||||
|
Interest
|
$ | — | $ | — | ||||
|
Taxes
|
$ | 98,000 | $ | 137,000 | ||||
|
NON CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
|
Value of shares and warrants issued to purchase patents
|
$ | 1,617,000 | $ | — | ||||
|
NINE MONTHS ENDED SEPTEMBER 30
,
|
|||
|
2013
|
2012
|
||
|
Risk-free interest rates
Expected option life in years
Expected stock price volatility
Expected dividend yield
|
0.78% -1.24%
5 years
43.54% - 44.31%
-0-
|
0.71%-0.89%
5 years
45.86%
- 0 -
|
|
|
Nine Months Ended
September 30,
|
Three Months Ended
September 30,
|
|||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
|||||||||||||
|
Weighted-average common shares outstanding – basic
|
25,387,348 | 25,659,085 | 25,792,387 | 25,963,093 | ||||||||||||
|
Dilutive effect of options and warrants
|
2,075,010 | 2,885,887 | 2,397,196 | 2,553,549 | ||||||||||||
|
Weighted-average common shares outstanding – diluted
|
27,462,358 | 28,544,972 | 28,189,583 | 28,516,642 | ||||||||||||
|
Options and Warrants excluded from the computation of diluted income (loss) per share because the effect of inclusion would have been anti-dilutive
|
5,132,490 | 2,574,113 | 4,810,304 | 2,906,451 | ||||||||||||
|
September 30, 2013
|
December 31, 2012
|
|||||||
|
Cash
|
$ | 1,823,000 | $ | 1,346,000 | ||||
|
Money market fund
|
17,761,000 | 20,637,000 | ||||||
|
Total
|
$ | 19,584,000 | $ | 21,983,000 | ||||
|
Number of
Shares
|
Value
|
|||||||
|
Common Stock
|
250,000 | $ | 76,000 | |||||
|
Series A Preferred Stock
|
123,456 | 50,000 | ||||||
|
Warrants
|
1,305,000 | 70,000 | ||||||
| $ | 196,000 | |||||||
| ● |
On July 22, 2013, Abacus & Associates, Inc. (“Abacus”) exercised a warrant to purchase 500,000 shares of our common stock at an exercise price of $2.05 per share and we issued (at the instructions of Abacus) 500,000 shares of our common stock to Sucaba LLC (440,000 shares) and Sucaba CRUT, LLC (60,000 shares), both affiliates of Abacus.
|
|
●
|
On July 26, 2013, we issued to Recognition Interface, LLC (“Recognition”) an additional 5-year warrant to purchase an aggregate of 250,000 shares of our common stock consisting of (i) warrants to purchase 125,000 shares at an exercise price of $2.10 per share and (ii) warrants to purchase 125,000 shares at an exercise price of $1.40 per share. These warrants were issued, pursuant to our agreement, dated May 21, 2013, with Recognition (an affiliate of Abacus) as a result of the above referenced warrant exercise by Abacus.
|
|
Period
|
Total Number of Shares Purchased
|
Average Price Paid Per Share
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
|
|
July 1 to
July 31, 2013
|
49,500
|
1.70
|
49,500
|
$2,166,162
|
|
August 1 to
August 31, 2013
(1)
|
27,712
|
1.72
|
27,712
|
$2,118,479
|
|
September 1 to
September 30, 2013
|
20,600
|
1.63
|
20,600
|
$2,084,919
|
|
(1)
|
Includes 15,112 shares of our common stock repurchased from Laurent Ohana, a former director, on August 17, 2013 at $1.775 per share or aggregate consideration of $26,824.
|
|
|
3(i)(a)
|
Certificate of Incorporation, as amended. Previously filed as Exhibit 3.1 to the Company's Registration Statement on Form SB-2 (Registration No. 333-59617), declared effective by the SEC on November 12,1998 (the "1998 Registration Statement"), and incorporated herein by reference.
|
|
|
3(i)(b)
|
Certificate of Amendment to the Certificate of Incorporation dated November 27, 2001. Previously filed as Exhibit 3.1.1 to the Company's Registration Statement on Form S-3 (Registration No. 333-81344) declared effective by the SEC on February 12, 2002, and incorporated herein by reference (the "February 2002 Form S-3").
|
|
|
3(i)(c)
|
Certificate of Amendment to the Certificate of Incorporation dated October 9, 2013. Previously filed as Exhibit 3.1 to the Company’s report on Form 8-K filed on October 10, 2013, and incorporated by reference.
|
|
|
31.1
|
Controls and Procedure Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Controls and Procedure Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
XBRL Instance Document
|
|
101.SCH
|
XBRL Schema Document
|
|
101.CAL
|
XBRL Calculation Linkbase Document
|
|
101.DEF
|
XBRL Definition Linkbase Document
|
|
101.LAB
|
XBRL Label Linkbase Document
|
|
NETWORK-1 TECHNOLOGIES, INC.
|
|||
|
|
|||
|
Date: November 14, 2013
|
By:
|
/s/ Corey M. Horowitz | |
| Corey M. Horowitz | |||
| Chairman and Chief Executive Officer | |||
|
Date: November 14, 2013
|
By:
|
/s/ David C. Kahn | |
| David C. Kahn | |||
|
Chief Financial Officer
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|